As CGRP-targeted therapies move into wider use, new data are beginning to clarify their role in special populations, the value of switching agents when one fails, and their long-term vascular safety.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/calcitonin-gene-related-peptide-drugs-migraine-evidence-gaps-2026a10005ks?src=rss
Author :
Publish date : 2026-02-23 12:29:00
Copyright for syndicated content belongs to the linked Source.
